Search Results - "Voorn, D.A."
-
1
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines
Published in Biochemical pharmacology (01-02-2004)“…1-β- d-Arabinofuranosylcytosine (ara-C) is a deoxycytidine analog with activity in leukemia, which requires phosphorylation by deoxycytidine kinase (dCK) to…”
Get full text
Journal Article -
2
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors
Published in Annals of oncology (01-04-1999)“…Purpose: To determine possible schedule dependent pharmacokinetic and pharmacodynamic interactions between gemcitabine (2',2'-difluorodeoxycytidine, dFdC) and…”
Get full text
Journal Article -
3
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours
Published in European journal of cancer (1990) (01-12-2000)“…The combination of 2′,2′-difluorodeoxycytidine (gemcitabine, dFdC) and cis-diammine-dichloroplatinum(II) (cisplatin, CDDP) is increasingly applied in clinical…”
Get full text
Journal Article -
4
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia
Published in European journal of cancer (1990) (01-03-2001)“…Acute myeloid leukaemia (AML) is thought to be methotrexate (MTX)-resistant. However, a small study suggested that acute monocytic leukemia (AML-M5) is…”
Get full text
Journal Article -
5
Mechanisms of synergism between gemcitabine (dFdC) and cisplatin (CDDP)
Published in Clinical biochemistry (01-04-1997)Get full text
Journal Article